Anti-atherogenic property of ferulic acid in apolipoprotein E-deficient mice fed Western diet: Comparison with clofibrate

Food and Chemical Toxicology

Volumn 48, Issue 8-9, 2010, Pages 2298-2303

  Kwon, E Y ^a   Do, G M ^a   Cho, Y Y ^a   Park, Y B ^a   Jeon, S M ^a   Choi, M S ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Apo E deficient mice; Atherosclerosis; Clofibrate; Ferulic acid; Oxidative stress

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; CATALASE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CLOFIBRATE; FERULIC ACID; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; ANTIOXIDANT; COUMARIC ACID; HYPOCHOLESTEROLEMIC AGENT; LIPID;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DRUG ACTIVITY; ENZYME ACTIVITY; EPIDIDYMIS; ERYTHROCYTE; FOOD INTAKE; HISTOPATHOLOGY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL; ATHEROSCLEROSIS; BLOOD; C57BL MOUSE; DRUG EFFECTS; EATING; GENETICS; KNOCKOUT MOUSE; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; APOLIPOPROTEINS E; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CLOFIBRATE; COUMARIC ACIDS; DIET; EATING; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID PEROXIDATION; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SIZE; STEROL O-ACYLTRANSFERASE; WEIGHT GAIN;

MUS;

EID: 77955056285     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.05.063     Document Type: Article

References (40)

1. Aebi H. Methods of enzymatic analysis. Catalase 1974, 673-784. Academic press, New York. H.U. Bergmeyer (Ed.).
2. Akkuş I., et al. Investigation of erythrocyte membrane lipid peroxidation and antioxidant defense systems of patients with coronary artery disease (CAD) documented by angiography. Clinica Chimica Acta; International Journal of Clinical Chemistry 1996, 244:173-180.
3. Alberts A.W. Discovery, biochemistry and biology of lovastatin. The American Journal of Cardiology 1988, 62:10J-15J.
4. Aviram M., et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. The Journal of Clinical Investigation 1998, 101:1581-1590.
5. Balasubashini M.S., et al. Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytotherapy Research 2004, 18:310-314.
6. Barter P.J., Rye K.A. High density lipoproteins and coronary heart disease. Atherosclerosis 1996, 121:1-12.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
8. Carew T.E. Role of biologically modified low-density lipoprotein in atherosclerosis. The American Journal of Cardiology 1989, 64:18G-22G.
9. Castelluccio C., et al. Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants. FEBS Letters 1995, 368:188-192.
10. Freeman B.A., Crapo J.D. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. The Journal of Biological Chemistry 1981, 256:10986-10992.
11. Gillies P.J., et al. Regulation of acyl-CoA:cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: role of a cholesterol substrate pool. Experimental and Molecular Pathology 1986, 44:329-339.
12. Goswami B., et al. Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction. Acta Cardiologica 2008, 63:749-755.
13. Halliwell B. Mechanism involved in the generation of free radicals. Pathologie et Biologie 1996, 44:6-13.
14. Haron, D., 1991. The aging - major risk factor for disease and death.In: Proceedings of the National Academy of Sciences of the United States of America, pp. 5360-5364.
15. Hayek T., et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosclerosis, Thrombosis, and Vascular Biology 1997, 17:2744-2752.
16. Heinonen T.M. Inhibition of acyl coenzyme A-cholesterol acyltransferase: a possible treatment of atherosclerosis?. Current Atherosclerosis Reports 2002, 4:65-70.
17. Hiramatsu K., et al. Effect of gamma-oryzanol on atheroma formation in hypercholesterolemic rabbits. The Tokai Journal of Experimental and Clinical Medicine 1990, 15:299-305.
18. Hollman P.C., Katan M.B. Bioavailability and health effects of dietary flavonols in man. Archives of Toxicology. Supplement 1998, 20:237-248.
19. Hudson E.A., et al. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiology, Biomarkers and Prevention 2000, 9:1163-1170.
20. Hulcher F.H., Oleson W.H. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. Journal of Lipid Research 1973, 14:625-631.
21. Luximon-Ramma A., et al. Assessment of the polyphenolic composition of the organic extracts of Mauritian black teas: a potential contributor to their antioxidant functions. BioFactors 1996, 27:79-91.
22. Mackness M.I., et al. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letters 1991, 286:152-154.
23. Mackness M.I., et al. Is paraoxonase related to atherosclerosis. Chemico-Biological Interactions 1993, 87:161-171.
24. Mackness M.I., et al. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993, 104:129-135.
25. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European Journal of Biochemistry 1974, 47:469-474.
26. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). The Journal of Biological Chemistry 1969, 244:6049-6055.
27. McElveen J., et al. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clinical Chemistry 1986, 32:671-673.
28. Miyazaki A., et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arteriosclerosis, Thrombosis, and Vascular biology 1998, 18:1568-1574.
29. Nakashima Y., et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 1994, 14:133-140.
30. Oi-Kano Y., et al. Oleuropein, a phenolic compound in extra virgin olive oil, increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. Journal of Nutritional Science and Vitaminology 2008, 54:363-370.
31. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The Journal of Laboratory and Clinical Medicine 1967, 70:158-169.
32. Palinski W., et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arteriosclerosis and Thrombosis 1994, 14:605-616.
33. Pigeolot E., et al. Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxide and oxygen derived radicals. Mechanisms of Ageing and Development 1990, 51:283-297.
34. Pinto R.E., Bartley W. The effect of age and sex on glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochemistry Journal 1969, 112:109.
35. Shapiro D.J., et al. Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochimica et Biophysica Acta 1974, 370:369-377.
36. Sugatani J., et al. Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet. European Journal of Nutrition 2008, 47:192-200.
37. Tkác I., et al. Carotid intima-media thickness in type 2 diabetes is more strongly related to serum apoprotein A-I in females. Wiener Klinische Wochenschrift 2001, 113:194-198.
38. Vijayakumar R.S., Nalini N. Efficacy of piperine, an alkaloidal consiuent from Piper nigrum on erythrocyte antioxidant status in high fat diet and antithyroid drug induced hyperlipidemic rats. Cell Biochemistry and Function 2006, 24:491-498.
39. Yan J.J., et al. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. British Journal of Pharmacology 2001, 133:89-96.
40. Zimetbaum P., et al. Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. Journal of Clinical Pharmacology 1991, 31:25-37.